Ipsilateral circumferential radiofrequency ablation of atrial fibrillation with irrigated tip catheter: Long-term outcome and Pre-procedural predictors

Circulation Journal

Volumn 77, Issue 9, 2013, Pages 2280-2287

  Wójcik, Maciej ^a,c   Erkapic, Damir ^b   Berkowitsch, Alexander ^a   Zaltsberg, Sergey ^a   Greiss, Harald ^a   Schmitt, Jörn ^b   Pajitnev, Dimitri ^a   Lehinant, Stefan ^a   Rixe, Johannes ^b   Hamm, Christian W ^a,b   Pitschner, Heinz F ^a   Kuniss, Malte ^a   Neumann, Thomas ^b  

^a Kerckhoff Heart and Thorax Center ^*  (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

^c MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Atrial fibrillation; Catheter ablation; Circumferential pulmonary antrum isolation; Predictors of outcome; Pulmonary vein isolation

Indexed keywords

HEPARIN;

ADULT; AGED; ARTICLE; CATHETER ABLATION; COMORBIDITY; ECHOCARDIOGRAPHY; FEMALE; FLUOROSCOPY; GLOMERULUS FILTRATION RATE; HEART ATRIUM FIBRILLATION; HEART LEFT ATRIUM; HEART TAMPONADE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERICARDIAL EFFUSION; PERICARDIOCENTESIS; PULMONARY VEIN ISOLATION; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; STENOSIS; SURVIVAL RATE; TACHYCARDIA; TRANSESOPHAGEAL ECHOCARDIOGRAPHY; TRANSIENT ISCHEMIC ATTACK; TREATMENT OUTCOME;

AGED; ATRIAL FIBRILLATION; CARDIAC CATHETERS; CATHETER ABLATION; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 84882795008     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.CJ-13-0275     Document Type: Article

References (49)

1. Go AS, Hylek EM, Phillips KA, Chang Y, Henault LE, Selby JV, et al. Prevalence of diagnosed atrial fibrillation in adults: National implications for rhythm management and stroke prevention: The anti-coagulation and risk factors in atrial fibrillation (atria) study. JAMA 2001; 285: 2370-2375.
2. AFFIRM First Antiarrhythmic Drug Substudy Investigators. Maintenance of sinus rhythm in patients with atrial fibrillation: An affrm substudy of the frst antiarrhythmic drug. J Am Coll Cardiol 2003; 42: 20-29.
3. Jons C, Hansen PS, Johannessen A, Hindricks G, Raatikainen P, Kongstad O, et al. The Medical ANtiarrhythmic Treatment or Radio-frequency Ablation in Paroxysmal Atrial Fibrillation (MANTRA-PAF) trial: Clinical rationale, study design, and implementation. Europace 2009; 11: 917-923.
4. Calkins H. Catheter ablation to maintain sinus rhythm. Circulation 2012; 125: 1439-1445.
5. Neumann T, Vogt J, Schumacher B, Dorszewski A, Kuniss M, Neuser H, et al. Circumferential pulmonary vein isolation with the cryoballoon technique: Results from a prospective 3-center study. J Am Coll Cardiol 2008; 52: 273-278.
6. Kumagai K. Catheter ablation of atrial fibrillation: State of the art. Circ J 2011; 75: 2305-2311.
7. Kim YH. Catheter ablation of longstanding persistent atrial fibrilla-tion: Are we on the right path? Circ J 2012; 76: 1299-1306.
8. Lip GY, Tse HF, Lane DA. Atrial fibrillation. Lancet 2012; 379: 648-661.
9. Wazni OM, Marrouche NF, Martin DO, Verma A, Bhargava M, Saliba W, et al. Radiofrequency ablation vs antiarrhythmic drugs as frst-line treatment of symptomatic atrial fibrillation: A randomized trial. JAMA 2005; 293: 2634-2640.
10. Pappone C, Augello G, Sala S, Gugliotta F, Vicedomini G, Gulletta S, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrilla-tion: The APAF study. J Am Coll Cardiol 2006; 48: 2340-2347.
11. Jais P, Cauchemez B, Macle L, Daoud E, Khairy P, Subbiah R, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: The A4 study. Circulation 2008; 118: 2498-2505.
12. Noheria A, Kumar A, Wylie JV Jr, Josephson ME. Catheter ablation vs antiarrhythmic drug therapy for atrial fibrillation: A systematic review. Arch Intern Med 2008; 168: 581-586.
13. Calkins H, Reynolds MR, Spector P, Sondhi M, Xu Y, Martin A, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radio-frequency ablation: Two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol 2009; 2: 349-361.
14. Piccini JP, Lopes RD, Kong MH, Hasselblad V, Jackson K, Al-Khatib SM. Pulmonary vein isolation for the maintenance of sinus rhythm in patients with atrial fibrillation: A meta-analysis of randomized, controlled trials. Circ Arrhythm Electrophysiol 2009; 2: 626-633.
15. Nair GM, Nery PB, Diwakaramenon S, Healey JS, Connolly SJ, Morillo CA. A systematic review of randomized trials comparing radiofrequency ablation with antiarrhythmic medications in patients with atrial fibrillation. J Cardiovasc Electrophysiol 2009; 20: 138-144.
16. Wilber DJ, Pappone C, Neuzil P, De Paola A, Marchlinski F, Natale A, et al. Comparison of antiarrhythmic drug therapy and radiofre-quency catheter ablation in patients with paroxysmal atrial fbrilla-tion: A randomized controlled trial. JAMA 2010; 303: 333-340.
17. Reynolds MR, Walczak J, White SA, Cohen DJ, Wilber DJ. Improvements in symptoms and quality of life in patients with paroxysmal atrial fibrillation treated with radiofrequency catheter ablation versus antiarrhythmic drugs. Circ Cardiovasc Qual Outcomes 2010; 3: 615-623.
18. European Heart Rhythm Association, European Association for Cardio-Thoracic Surgery, Camm AJ, Kirchhof P, Lip GY, Schotten U, Savelieva I, Ernst S, et al. Guidelines for the management of atrial fibrillation: The Task Force for the Management of Atrial Fibrillation of the European Society of Cardiology (ESC). Eur Heart J 2010; 31: 2369-2429.
19. Calkins H, Kuck KH, Cappato R, Brugada J, Camm AJ, Chen SA, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: Recommendations for patient selection, procedural techniques, patient management and follow-up, defnitions, endpoints, and research trial design. J Interv Card Electrophysiol 2012; 33: 171-257.
20. Weerasooriya R, Khairy P, Litalien J, Macle L, Hocini M, Sacher F, et al. Catheter ablation for atrial fibrillation: Are results maintained at 5 years of follow-up? J Am Coll Cardiol 2011; 57: 160-166.
21. Shah AN, Mittal S, Sichrovsky TC, Cotiga D, Arshad A, Maleki K, et al. Long-term outcome following successful pulmonary vein isolation: Pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol 2008; 19: 661-667.
22. Ouyang F, Tilz R, Chun J, Schmidt B, Wissner E, Zerm T, et al. Long-term results of catheter ablation in paroxysmal atrial fibrilla-tion: Lessons from a 5-year follow-up. Circulation 2010; 122: 2368-2377.
23. Berkowitsch A, Neumann T, Kuniss M, Janin S, Wojcik M, Zaltsberg S, et al. Therapy with renin-angiotensin system blockers after pulmonary vein isolation in patients with atrial fibrillation: Who is a re-sponder? Pacing Clin Electrophysiol 2010; 33: 1101-1111.
24. Berkowitsch A, Neumann T, Kuniss M, Brandt R, Zaltsberg S, Pitschner HF. Evaluation of atrial fibrillation burden before catheter ablation predicts outcome after pulmonary vein isolation. Indian Pacing Electrophysiol J 2009; 9: 138-150.
25. Neumann T, Kuniss M, Erkapic D, Zaltsberg S, Berkowitsch A, Pajitnev D, et al. Acute and long-term results of PVI at antrum using a novel high-density mapping catheter without help of 3D electro-anatomic mapping in patients with paroxysmal and chronic atrial fibrillation. J Interv Card Electrophysiol 2010; 27: 101-108.
26. Cappato R, Calkins H, Chen SA, Davies W, Iesaka Y, Kalman J, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol 2010; 3: 32-38.
27. Gaita F, Caponi D, Scaglione M, Montefusco A, Corleto A, Di Monte F, et al. Long-term clinical results of 2 different ablation strategies in patients with paroxysmal and persistent atrial fibrilla-tion. Circ Arrhythm Electrophysiol 2008; 1: 269-275.
28. Fiala M, Chovancik J, Nevralova R, Neuwirth R, Jiravsky O, Nykl I, et al. Pulmonary vein isolation using segmental versus electroana-tomical circumferential ablation for paroxysmal atrial fibrillation: Over 3-year results of a prospective randomized study. J Interv Card Electrophysiol 2008; 22: 13-21.
29. Bertaglia E, Tondo C, De Simone A, Zoppo F, Mantica M, Turco P, et al. Does catheter ablation cure atrial fibrillation? Single-procedure outcome of drug-refractory atrial fibrillation ablation: A 6-year mul-ticentre experience. Europace 2010; 12: 181-187.
30. Sato Y, Yoshida K, Ogata K, Inaba T, Tada H, Sekiguchi Y, et al. An increase in right atrial magnetic strength is a novel predictor of recurrence of atrial fibrillation after radiofrequency catheter ablation. Circ J 2012; 76: 1601-1608.
31. Rostock T, Salukhe TV, Steven D, Drewitz I, Hoffmann BA, Bock K, et al. Long-term single- and multiple-procedure outcome and predictors of success after catheter ablation for persistent atrial fibril-lation. Heart Rhythm 2011; 8: 1391-1397.
32. McCready JW, Smedley T, Lambiase PD, Ahsan SY, Segal OR, Rowland E, et al. Predictors of recurrence following radiofrequency ablation for persistent atrial fibrillation. Europace 2011; 13: 355-361.
33. Bhargava M, Di Biase L, Mohanty P, Prasad S, Martin DO, Williams-Andrews M, et al. Impact of type of atrial fibrillation and repeat catheter ablation on long-term freedom from atrial fibrillation: Results from a multicenter study. Heart Rhythm 2009; 6: 1403-1412.
34. Winkle RA, Mead RH, Engel G, Kong MH, Patrawala RA. Prior antiarrhythmic drug use and the outcome of atrial fibrillation ablation. Europace 2012; 14: 646-652.
35. Moe GK. On the multiple wavelet hypothesis of atrial fibrillation. Arch Int Pharmacodyn Ther 1962; 140: 183-188.
36. Damiano RJ Jr, Gaynor SL, Bailey M, Prasad S, Cox JL, Boineau JP, et al. The long-term outcome of patients with coronary disease and atrial fibrillation undergoing the Cox maze procedure. J Thorac Cardiovasc Surg 2003; 126: 2016-2021.
37. Mulder AA, Wijffels MC, Wever EF, Boersma LV. Freedom from paroxysmal atrial fibrillation after successful pulmonary vein isolation with pulmonary vein ablation catheter-phased radiofrequency energy: 2-year follow-up and predictors of failure. Europace 2012; 14: 818-825.
38. Berkowitsch A, Kuniss M, Greiss H, Wojcik M, Zaltsberg S, Lehinant S, et al. Impact of impaired renal function and metabolic syndrome on the recurrence of atrial fibrillation after catheter ablation: A long term follow-up. Pacing Clin Electrophysiol 2012; 35: 532-543.
39. Naruse Y, Tada H, Sekiguchi Y, Machino T, Ozawa M, Yamasaki H, et al. Concomitant chronic kidney disease increases the recurrence of atrial fibrillation after catheter ablation of atrial fibrillation: A midterm follow-up. Heart Rhythm 2011; 8: 335-341.
40. Tokuda M, Yamane T, Matsuo S, Ito K, Narui R, Hioki M, et al. Relationship between renal function and the risk of recurrent atrial fibrillation following catheter ablation. Heart 2011; 97: 137-142.
41. Chao TF, Lin YJ, Chang SL, Lo LW, Hu YF, Tuan TC, et al. Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibril-lation. Circ J 2011; 75: 2326-2332.
42. Tuininga YS, Wiesfeld AC, van Veldhuisen DJ, van Gelder IC, Crijns HJ. Electrophysiological changes of angiotensin-converting enzyme inhibition after myocardial infarction. J Card Fail 2000; 6: 77-79.
43. Botto GL, Luzi M, Sagone A. Atrial fibrillation: The remodelling phenomenon. Eur Heart J Suppl 2003; 5(Suppl H): H1-H7.
44. St John Sutton M, Lee D, Rouleau JL, Goldman S, Plappert T, Braunwald E, et al. Left ventricular remodeling and ventricular arrhythmias after myocardial infarction. Circulation 2003; 107: 2577-2582.
45. Kannel WB, Wolf PA, Benjamin EJ, Levy D. Prevalence, incidence, prognosis, and predisposing conditions for atrial fibrillation: Population-based estimates. Am J Cardiol 1998; 82: 2N-9N.
46. Balk EM, Garlitski AC, Alsheikh-Ali AA, Terasawa T, Chung M, Ip S. Predictors of atrial fibrillation recurrence after radiofrequency catheter ablation: A systematic review. J Cardiovasc Electrophysiol 2010; 21: 1208-1216.
47. Themistoclakis S, Schweikert RA, Saliba WI, Bonso A, Rossillo A, Bader G, et al. Clinical predictors and relationship between early and late atrial tachyarrhythmias after pulmonary vein antrum isolation. Heart Rhythm 2008; 5: 679-685.
48. Berruezo A, Tamborero D, Mont L, Benito B, Tolosana JM, Sitges M, et al. Pre-procedural predictors of atrial fibrillation recurrence after circumferential pulmonary vein ablation. Eur Heart J 2007; 28: 836-841.
49. Calvo N, Nadal M, Berruezo A, Andreu D, Arbelo E, Tolosana JM, et al. Improved outcomes and complications of atrial fibrillation catheter ablation over time: Learning curve, techniques, and methodology. Rev Esp Cardiol (Engl Ed) 2012; 65: 131-138.